The Bacillus Calmette-Guerin (BCG) Vaccine market was valued at USD 61.84 Billion in 2024 and is expected to reach USD 92.02 Billion by 2032, growing at a CAGR of 5.1% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.